TB-500 is a synthetic version of the active region of thymosin beta-4 (Tβ4), a 43-amino acid polypeptide present in virtually all mammalian tissues and cell types. The name “TB-500” refers specifically to a commercially available synthetic peptide sequence used in research applications.
Actin Binding
Thymosin beta-4’s primary intracellular function is sequestering monomeric G-actin, maintaining the pool of unpolymerized actin available for rapid cytoskeletal reorganization. The actin-binding domain (residues 17–22, the LKKTET sequence) is preserved in TB-500 and is essential for this function.
Extracellular Functions
Beyond its cytoplasmic actin-sequestering role, Tβ4/TB-500 is released extracellularly where it promotes cell migration, angiogenesis, and wound healing. The N-terminal tetrapeptide Ac-SDKP (released by enzymatic cleavage) has distinct anti-fibrotic and anti-inflammatory properties.
Research Context
TB-500 is studied in tissue repair, cardiac function, and dermal wound healing models. Its ability to promote cell migration through upregulation of matrix metalloproteinases and downregulation of inflammatory cytokines makes it relevant to regenerative research.